scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/nar/BrouWASLDCT93 |
P356 | DOI | 10.1093/NAR/21.1.5 |
P932 | PMC publication ID | 309058 |
P698 | PubMed publication ID | 8441620 |
P5875 | ResearchGate publication ID | 14756931 |
P50 | author | László Tora | Q42136955 |
Irwin Davidson | Q42444538 | ||
P2093 | author name string | J Wu | |
E Scheer | |||
S Ali | |||
C Brou | |||
C Lang | |||
P Chambon | |||
P2860 | cites work | Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription | Q24337785 |
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties | Q24567487 | ||
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes | Q27860623 | ||
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins | Q27861094 | ||
The steroid and thyroid hormone receptor superfamily | Q27861095 | ||
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently | Q28208673 | ||
Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1 | Q28282333 | ||
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation | Q28303864 | ||
A novel mediator between activator proteins and the RNA polymerase II transcription apparatus | Q28642649 | ||
Five intermediate complexes in transcription initiation by RNA polymerase II | Q29616444 | ||
GAL4-VP16 is an unusually potent transcriptional activator | Q29616453 | ||
The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
Gene regulation by steroid hormones | Q29618291 | ||
Mechanism of transcriptional activation by Sp1: evidence for coactivators | Q29620214 | ||
The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon | Q33564956 | ||
The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors | Q33879781 | ||
The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes | Q33937872 | ||
A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergistically | Q48185247 | ||
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. | Q54251780 | ||
Factors involved in specific transcription in mammalian RNA polymerase II. Functional analysis of initiation factors IIA and IID and identification of a new factor operating at sequences downstream of the initiation site. | Q54410067 | ||
The mammalian TFIID protein is present in two functionally distinct complexes. | Q54689250 | ||
Expression and function of the human estrogen receptor in yeast. | Q54756007 | ||
Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor | Q59063048 | ||
Negative effect of the transcriptional activator GAL4 | Q59072863 | ||
Formation of stable preinitiation complexes between eukaryotic class B transcription factors and promoter sequences | Q59074628 | ||
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets | Q59098114 | ||
Steroid hormone receptors compete for factors that mediate their enhancer function | Q61818663 | ||
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro | Q68111216 | ||
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function | Q68433333 | ||
A potent GAL4 derivative activates transcription at a distance in vitro | Q68928249 | ||
Functional domains of the human estrogen receptor | Q69466265 | ||
Mechanism of action of an acidic transcriptional activator in vitro | Q70113517 | ||
Transcription initiated by RNA polymerase II and transcription factors from liver. Structure and action of transcription factors epsilon and tau | Q70141682 | ||
RNA polymerase B (II) and general transcription factors | Q34222071 | ||
Cloning of the 62-kilodalton component of basic transcription factor BTF2. | Q34338584 | ||
Activation of class II gene transcription by regulatory factors is potentiated by a novel activity | Q34855093 | ||
The Drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor superfamily | Q34920066 | ||
In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators | Q35013886 | ||
Advances in RNA polymerase II transcription | Q35673499 | ||
Transcription activation by estrogen and progesterone receptors | Q36468309 | ||
Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex | Q36774375 | ||
Mechanism of estrogen receptor-dependent transcription in a cell-free system | Q36775149 | ||
Identification of a coactivator that increases activation of transcription by serum response factor and GAL4-VP16 in vitro | Q37053594 | ||
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID | Q37531197 | ||
Evidence for a factor required for transcriptional stimulation by the chimeric acidic activator GAL-VP16 in HeLa cell extracts | Q37586227 | ||
Activators and targets | Q37856107 | ||
Regulation of gene expression by nuclear hormone receptors | Q38326537 | ||
Distinct classes of transcriptional activating domains function by different mechanisms | Q38339126 | ||
Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors | Q38340343 | ||
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor | Q38341530 | ||
Identification of two transactivation domains in the mouse oestrogen receptor | Q38344037 | ||
Nuclear receptors enhance our understanding of transcription regulation | Q39324380 | ||
The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells | Q41870113 | ||
Purification of a factor specific for the upstream element of the adenovirus-2 major late promoter | Q42091553 | ||
Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex | Q42468497 | ||
Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription | Q42472464 | ||
Family of proteins that interact with TFIID and regulate promoter activity | Q42473645 | ||
Physical Analysis of Transcription Preinitiation Complex Assembly on a Class II Gene Promoter | Q45226839 | ||
Transcription from a TATA-less promoter requires a multisubunit TFIID complex | Q46109338 | ||
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction | Q46609056 | ||
Separation and characterization of factors mediating accurate transcription by RNA polymerase II. | Q47956947 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | estrogen | Q277954 |
P304 | page(s) | 5-12 | |
P577 | publication date | 1993-01-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor | |
P478 | volume | 21 |
Q40792892 | A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth. |
Q35000751 | A TBP-containing multiprotein complex (TIF-IB) mediates transcription specificity of murine RNA polymerase I |
Q42657392 | A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1. |
Q39722071 | A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators |
Q37132891 | A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development |
Q41284016 | Activation function 1 of retinoic acid receptor beta 2 is an acidic activator resembling VP16. |
Q37726327 | Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates |
Q28263487 | Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1 |
Q37726329 | Chromatin remodeling and nuclear receptor signaling. |
Q27937428 | Cloning and characterization of an essential Saccharomyces cerevisiae gene, TAF40, which encodes yTAFII40, an RNA polymerase II-specific TATA-binding protein-associated factor |
Q24315758 | Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID |
Q24797549 | Coordinate regulation of RARgamma2, TBP, and TAFII135 by targeted proteolysis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells |
Q38295125 | Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription. |
Q24562199 | Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex |
Q24320008 | Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II |
Q24324051 | Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors |
Q24321811 | Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor |
Q28242358 | Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair |
Q40106128 | Interaction of estrogen receptor alpha with proliferating cell nuclear antigen |
Q40791998 | Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators |
Q41526912 | Modified steroid receptors and steroid-inducible promoters as genetic switches for gene therapy |
Q34388525 | Multiple interactions between hTAFII55 and other TFIID subunits. Requirements for the formation of stable ternary complexes between hTAFII55 and the TATA-binding protein |
Q24323091 | Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor |
Q28910378 | Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB |
Q42498731 | Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells |
Q34043346 | Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease |
Q71747785 | Retinoid-dependent in vitro transcription |
Q36633683 | Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription f |
Q33837314 | Selective oestrogen receptor modulation: molecular pharmacology for the millennium |
Q73534497 | Selective oestrogen receptor modulation: molecular pharmacology for the millennium |
Q40409585 | Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II. |
Q41104476 | Stimulation of transcription in vitro from a liver-specific promoter by human glucocorticoid receptor (hGRα) |
Q33351996 | TAF6delta controls apoptosis and gene expression in the absence of p53. |
Q33526062 | TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53. |
Q33958193 | TAFII40 protein is encoded by the e(y)1 gene: biological consequences of mutations |
Q24554379 | The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1 |
Q28142781 | The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties |
Q40791117 | The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters |
Q24291405 | The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger |
Q40021717 | The X protein of hepatitis B virus coactivates potent activation domains |
Q40416675 | The major histocompatibility complex (MHC) Ea promoter: sequences and factors at the initiation site. |
Q34107355 | The multicoloured world of promoter recognition complexes. |
Q33969106 | The novel transcription factor e(y)2 interacts with TAF(II)40 and potentiates transcription activation on chromatin templates |
Q38308499 | Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides |
Q38298143 | Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein |
Q34716188 | Trap a gene and find out its function: toward functional genomics in Drosophila |
Q34055015 | Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III |
Search more.